Eisai Co., Ltd.

This was an early safety study of an experimental drug called E7090 for people with advanced solid tumors that had stopped responding to standard treatments. The study involved 40 participants and had two main goals: first, to find the highest safe dose of the drug, and second, t…

This study tested whether the drug E7090 could help people with advanced bile duct cancer that had a specific genetic change (FGFR2 fusion) and had stopped responding to standard chemotherapy. The trial involved 63 participants and measured how much their tumors shrank and how lo…

This study tested a new drug called H3B-6545 in Japanese women with a specific, hard-to-treat type of advanced breast cancer. The main goal was to check if the drug was safe and well-tolerated in this group, and to find a suitable dose. It involved 33 women whose cancer had progr…